- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04290832
Developing and Testing Interventions to Address Conscientious Objection to Abortion Care in Mexico and South Africa
Developing and Testing Interventions to Address Use of Conscientious Objection to Deny Women's Access to Abortion Care in Mexico and South Africa
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Conscientious objection (CO) is emerging as a growing barrier to abortion care, and evidence suggests that it is being incorrectly used as a justification for public sector medical providers and institutions to exempt themselves from their duties to provide essential reproductive health services for women. Given this, it is essential to better understand and address this misuse of CO and find ways to improve women's access to safe abortion services to prevent them from using unsafe methods which risk their health and lives.
This study will conduct formative research to more fully understand the problem of CO in Mexico and South Africa and use these findings to develop interventions and strategies to mitigate the impact of CO on women's access to safe abortion care using a user-centered design approach. Rapid randomized controlled trials will then be used to assess effectiveness of the interventions. The specific aims of this study are:
- Improve our understanding of CO and its impact on access and quality of abortion care from providers' and facility mangers' perspectives in Mexico, and South Africa.
- Develop strategies and interventions to mitigate the impact of CO on women's access to safe abortion care. Using the data collected, a multi-disciplinary Innovation Team will develop strategies and interventions to respond to the challenges posed by CO using a user-centered design approach.
- Rapid-test intervention prototypes. We will test selected strategies (prototypes) in Mexico, and South Africa with assessments to determine successes, and the feasibility of scaling up these approaches.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mexico City, Mexico
- Ipas Central America and Mexico
-
-
-
-
-
Johannesburg, South Africa
- Ipas South Africa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
South Africa
Inclusion Criteria:
- All staff currently working in selected health facilities
- Able to provide informed consent
Exclusion Criteria:
- Unable to provide informed consent
Mexico
Inclusion Criteria:
- Doctors/anyone eligible to be an abortion provider working in selected health facilities
- Able to provide informed consent
Exclusion Criteria:
- Unable to provide informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: CO intervention
South Africa: All health facility staff working in facilities assigned to the intervention arm receive standard Ipas support (including monitoring of abortion service provision and support to Ipas-trained abortion providers) plus the CO intervention. Mexico: Doctors/anyone eligible to be an abortion provider working in facilities assigned to the intervention arm receive the CO intervention. |
South Africa: Values clarification and attitude transformation (VCAT) workshop with conscientious objection content, debrief session(s) with termination of pregnancy (TOP) providers to give them an opportunity to share concerns/challenges, meeting(s) with facility mangers to facilitate continued support and provision of TOP care Mexico: Training on abortion and conscientious objection law, posters on law, offer of legal assistance for abortion providers, scholarship to attend conference awarded on basis of quality of abortion care |
NO_INTERVENTION: Control
South Africa: All health facility staff working in facilities assigned to the control arm receive standard Ipas support (including monitoring of abortion service provision and support to Ipas-trained abortion providers). Mexico: No intervention |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Behavior making it easier for women to access abortion care
Time Frame: Past 30 days
|
Proportion of health facility staff exhibiting at least one behavior to make it easier for women to access abortion care (e.g.
helped a woman find the abortion care unit, provided positive support to a woman seeking abortion care, gave accurate information to a woman seeking abortion care, etc.).
|
Past 30 days
|
Behavior making it more difficult for women to access abortion care
Time Frame: Past 30 days
|
Proportion of health facility staff exhibiting at least one behavior to make it more difficult for women to access abortion care (e.g.
gave incorrect directions to a woman seeking abortion care, told a woman abortion services were not available at the facility, tried to convince a woman that she should not have an abortion, etc.).
|
Past 30 days
|
Intention to provide abortion service, referral, or information
Time Frame: Next few days
|
Proportion of health facility staff reporting they would provide abortion service, referral or information to women seeking abortion care in their health unit in the next few days if needed.
|
Next few days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Interest in attending an abortion care training
Time Frame: Assessed at baseline and at 30-day follow-up
|
Proportion of providers (doctors, nurses, or midwives) reporting being interested in attending an abortion care training.
|
Assessed at baseline and at 30-day follow-up
|
Stigmatizing Attitudes Beliefs and Actions Scale (SABAS) score
Time Frame: Assessed at baseline and at 30-day follow-up
|
Average Stigmatizing Attitudes Beliefs and Actions Scale (SABAS) score.
The SABAS is a tool designed to measure abortion stigma at the individual and community level, ranging from a minimum of 18 to a maximum of 90.
A higher score represents more stigmatizing attitudes and beliefs about women who have an abortion (worse outcome).
|
Assessed at baseline and at 30-day follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Erin Pearson, PhD, MPH, Ipas
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TIE_2020_01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abortion, Induced
-
Boston UniversityCompletedAbortion, Induced | Abortion, Second TrimesterUnited States
-
Boston UniversityCompletedAbortion, Induced | Abortion, Second TrimesterUnited States
-
Medstar Health Research InstituteCompleted
-
Planned Parenthood of Greater New YorkCompletedAbortion, InducedUnited States
-
Wolfson Medical CenterUnknown
-
Gynuity Health ProjectsCompletedAbortion, InducedMoldova, Republic of, Tunisia
-
Gynuity Health ProjectsCompleted
-
Gynuity Health ProjectsCentre de Formation et de la Recherche, TunisiaCompleted
-
Gynuity Health ProjectsUniversity of Puerto RicoTerminatedAbortion, InducedPuerto Rico
-
Nilratan Sircar Medical CollegeCompleted
Clinical Trials on CO Intervention
-
Hopitaux de Saint-MauriceInstitut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaboratorsCompleted
-
Sykehuset TelemarkUniversity of Oslo; Lund University; Oslo University Hospital; University of Minnesota and other collaboratorsRecruitingCerebral PalsyCanada, United States, Finland, Norway, Sweden
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)Active, not recruitingQuality of Life | Multimorbidity | Symptom ManagementUnited States
-
Johns Hopkins Bloomberg School of Public HealthPatient-Centered Outcomes Research InstituteCompletedCardiovascular Disease | Diabetes | Mental Health Disorder | Substance Abuse DisorderUnited States
-
Dana-Farber Cancer InstituteRecruitingGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Gastrointestinal CancerUnited States
-
Glasgow Caledonian UniversityCompletedPhysical Activity | Sedentary Behaviour | Care Home ResidentsUnited Kingdom
-
Manchester University NHS Foundation TrustRecruitingProlapse; Female | Prolapse, VaginalUnited Kingdom
-
Unity Health TorontoCovenant House Toronto; The Resource Association for Teens (RAFT); StepStones... and other collaboratorsActive, not recruiting
-
Haukeland University HospitalCompleted